1218199

Alexion Pharmaceuticals, Inc. — FEI 3014801948

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 30, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)